Healthcare · coverage Aug 15, 2024–Oct 30, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Thomas H. Kean
$1K - $15K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Nov 12, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving ABT. It is useful for seeing which lawmakers reported ABT transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Oct 30, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 52 public STOCK Act disclosures for ABTacross 20 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent ABT filing shown here was filed on Oct 30, 2026 by Thomas H. Kean as a partial sale. Related lawmakers include Josh Gottheimer, Richard McCormick, Jared Moskowitz, Thomas H. Kean, Byron Donalds.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent ABT disclosures include Josh Gottheimer, Richard McCormick, Jared Moskowitz, Thomas H. Kean, Byron Donalds.
The visible sample currently shows 27 purchases and 25 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
